AMCGX | PMAQX | AMCGX / PMAQX | |
Total Expense Ratio | 1.99 | 0.59 | 337% |
Annual Report Gross Expense Ratio | 1.99 | 0.59 | 337% |
Fund Existence | 32 years | 9 years | - |
Gain YTD | 11.123 | 8.761 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 268M | 33.2B | 1% |
Annual Yield % from dividends | 0.00 | 0.19 | - |
Returns for 1 year | 24.74 | 13.98 | 177% |
Returns for 3 years | 56.98 | 50.84 | 112% |
Returns for 5 years | -15.79 | 58.81 | -27% |
Returns for 10 years | 17.55 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VSENX | 55.32 | 0.54 | +0.99% |
JPMorgan Small Cap Equity R6 | |||
FPHAX | 26.09 | 0.17 | +0.66% |
Fidelity Select Pharmaceuticals Port | |||
BOPCX | 15.72 | 0.08 | +0.51% |
Sterling Capital Special Opps C | |||
SFCWX | 75.58 | 0.38 | +0.51% |
American Funds SMALLCAP World F3 | |||
SCJIX | 8.08 | 0.02 | +0.25% |
Steward Covered Call Income I |